Cargando…

Cell cycle responses to Topoisomerase II inhibition: Molecular mechanisms and clinical implications

DNA Topoisomerase IIA (Topo IIA) is an enzyme that alters the topological state of DNA and is essential for the separation of replicated sister chromatids and the integrity of cell division. Topo IIA dysfunction activates cell cycle checkpoints, resulting in arrest in either the G2-phase or metaphas...

Descripción completa

Detalles Bibliográficos
Autores principales: Soliman, Tanya N., Keifenheim, Daniel, Parker, Peter J., Clarke, Duncan J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Rockefeller University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641588/
https://www.ncbi.nlm.nih.gov/pubmed/37955972
http://dx.doi.org/10.1083/jcb.202209125
_version_ 1785146801360207872
author Soliman, Tanya N.
Keifenheim, Daniel
Parker, Peter J.
Clarke, Duncan J.
author_facet Soliman, Tanya N.
Keifenheim, Daniel
Parker, Peter J.
Clarke, Duncan J.
author_sort Soliman, Tanya N.
collection PubMed
description DNA Topoisomerase IIA (Topo IIA) is an enzyme that alters the topological state of DNA and is essential for the separation of replicated sister chromatids and the integrity of cell division. Topo IIA dysfunction activates cell cycle checkpoints, resulting in arrest in either the G2-phase or metaphase of mitosis, ultimately triggering the abscission checkpoint if non-disjunction persists. These events, which directly or indirectly monitor the activity of Topo IIA, have become of major interest as many cancers have deficiencies in Topoisomerase checkpoints, leading to genome instability. Recent studies into how cells sense Topo IIA dysfunction and respond by regulating cell cycle progression demonstrate that the Topo IIA G2 checkpoint is distinct from the G2-DNA damage checkpoint. Likewise, in mitosis, the metaphase Topo IIA checkpoint is separate from the spindle assembly checkpoint. Here, we integrate mechanistic knowledge of Topo IIA checkpoints with the current understanding of how cells regulate progression through the cell cycle to accomplish faithful genome transmission and discuss the opportunities this offers for therapy.
format Online
Article
Text
id pubmed-10641588
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-106415882023-11-14 Cell cycle responses to Topoisomerase II inhibition: Molecular mechanisms and clinical implications Soliman, Tanya N. Keifenheim, Daniel Parker, Peter J. Clarke, Duncan J. J Cell Biol Review DNA Topoisomerase IIA (Topo IIA) is an enzyme that alters the topological state of DNA and is essential for the separation of replicated sister chromatids and the integrity of cell division. Topo IIA dysfunction activates cell cycle checkpoints, resulting in arrest in either the G2-phase or metaphase of mitosis, ultimately triggering the abscission checkpoint if non-disjunction persists. These events, which directly or indirectly monitor the activity of Topo IIA, have become of major interest as many cancers have deficiencies in Topoisomerase checkpoints, leading to genome instability. Recent studies into how cells sense Topo IIA dysfunction and respond by regulating cell cycle progression demonstrate that the Topo IIA G2 checkpoint is distinct from the G2-DNA damage checkpoint. Likewise, in mitosis, the metaphase Topo IIA checkpoint is separate from the spindle assembly checkpoint. Here, we integrate mechanistic knowledge of Topo IIA checkpoints with the current understanding of how cells regulate progression through the cell cycle to accomplish faithful genome transmission and discuss the opportunities this offers for therapy. Rockefeller University Press 2023-11-13 /pmc/articles/PMC10641588/ /pubmed/37955972 http://dx.doi.org/10.1083/jcb.202209125 Text en © 2023 Soliman et al. https://creativecommons.org/licenses/by/4.0/This article is available under a Creative Commons License (Attribution 4.0 International, as described at https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Soliman, Tanya N.
Keifenheim, Daniel
Parker, Peter J.
Clarke, Duncan J.
Cell cycle responses to Topoisomerase II inhibition: Molecular mechanisms and clinical implications
title Cell cycle responses to Topoisomerase II inhibition: Molecular mechanisms and clinical implications
title_full Cell cycle responses to Topoisomerase II inhibition: Molecular mechanisms and clinical implications
title_fullStr Cell cycle responses to Topoisomerase II inhibition: Molecular mechanisms and clinical implications
title_full_unstemmed Cell cycle responses to Topoisomerase II inhibition: Molecular mechanisms and clinical implications
title_short Cell cycle responses to Topoisomerase II inhibition: Molecular mechanisms and clinical implications
title_sort cell cycle responses to topoisomerase ii inhibition: molecular mechanisms and clinical implications
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641588/
https://www.ncbi.nlm.nih.gov/pubmed/37955972
http://dx.doi.org/10.1083/jcb.202209125
work_keys_str_mv AT solimantanyan cellcycleresponsestotopoisomeraseiiinhibitionmolecularmechanismsandclinicalimplications
AT keifenheimdaniel cellcycleresponsestotopoisomeraseiiinhibitionmolecularmechanismsandclinicalimplications
AT parkerpeterj cellcycleresponsestotopoisomeraseiiinhibitionmolecularmechanismsandclinicalimplications
AT clarkeduncanj cellcycleresponsestotopoisomeraseiiinhibitionmolecularmechanismsandclinicalimplications